繁體中文 简体中文 Sitemap Previous Page
1945
Company predecessor, Glucose Corporation, instilled.

Oct. 1962
Company reorganized as Sintong Chemical Industry Company, Limited with $35 million paid-in capitalization as an integrated local pharmaceutical producer.

1979
20ml BFS filler machine procured marking the firm as a premiere local SVPˇ] small volume parenteralˇ^producer.

1987
* Paid-in capitalization upped to $200 million with IPO completed and passed GMPˇ]Good Manufacture Practiceˇ^inspection.
* Representation of Japan's Nikkiso hemodialysis equipment as the agency embarked on the medical treatment equipment and related field.
* Exports reaching Vietnam to excel Sintong in global expansion.
* Full computerization inducted.

1988
Launched the first bio-equivalent test product in Taiwan, Ranidine, formally certified by the Department of Health.

1989
* Addition of 20ml BFS filling machine.
* Investment in Taiwan Biotech Co., Ltd offering upstream Active Pharmaceutical Ingredients (APIs).

1990
* Technical pact with the Japanese Eisai in jointly producing Aminol-K and the presentation of many of its related products.
* Joint development of transdermal delivery drug system (TDDS) with an U.S.A. Pharmaceutical Development company.

1992
* Accredited with Outstanding Award in the first Outstanding Biotech Awards by the Ministry of Economic Affairs.
* Bestowed with a pilot new product R&D plan for transdermal products sanctioned by the Ministry of Economic Affairs' Bureau of Industrial Development.

1993
* Accredited with an Outstanding Award by the ROC Biotech Industry Development Council.
* Branch office launched at the Hsinchu Science-based Industrial Park.

1994 * Curie Chemicals and Pharmaceuticals Manufacturing Co., Ltd's plant joined Taiwan Biotech's production line in producing oral products.
* The addition of 10ml BFS filler machine.
* API plant certified by the U.S. Food & Drug Administration.

1995 Innovative transdermal nicotine patch, Smokfree, debuted.

1996 AnPo, a labour inhibitors, debuted.

1997 Export of a 20ml BFSˇ]Bill-Flow-Sealˇ^to Japan began

1998 * Reinvestments made at Huaneng Pharmaceutical Company in Mainland China.
* Dynamics Venture Capital formed in a move to integrate the company's venture investments.

1999 * Represent the U.S. pharmaceutical company, Ocular Sciences' contact lenses.
* Sales and marketing of respiratory system medical equipment, began.
* Investments made to the U.S. company, Optics Corporation, through which TBC's products started to export to the U.S.

2001 * Renamed as Taiwan Biotech Company, Limited.-
* Represent the U.S. pharmaceutical company, Cephalon's Provigil- a narcolepsy treatment solution.-
* Implemented and surpassed the cGMP phase-one review.

2002 * Biotech food manufactory launched at the Hsinchu Science-based Industrial Park.
* Strategic alliance formed with Fresenius Medical Care Corporation of Germany.

2003 Implemented and surpassed the cGMP(II)-process validation review.

2004 * Accredited with pharmaceutical technology research award in the third pharmaceutical technology research awards by the department of health executive yuan.
* Accredited with orphan drug research award in the third orphan drug research awards by the department of health executive yuan.

2005 * Implemented and surpassed the cGMP(III)-computer validation review.
* Accredited with pharmaceutical technology research award in the forth pharmaceutical technology research awards by department of health executive yuan.
* Eye-Cept Rewetting Drops got FDAˇ¦s approval of 510(k) for contact lens care products in USA.
* Purchasing the Kuan Yin plant of Fujisawa Pharmaceutical Co., Ltd in Taiwan.
* Acquired management authority of The Veterans Pharmaceutical Plant.



Contact : International Trade Division
Email : trade-a@sintong.com
Address : No.22, Chieh-shou Road, Taoyuan, Taiwan
Taipei Office : +886-2-2351-9839
Tel : +886-3-361-2131
Fax : +886-3-367-0029

|
22, Jie Shou Road,Taoyuan 33062,Taiwan   TEL: 886-3-3612131   FAX: 886-3-3670029   E-mail: admit-hr@sintong.com   Copyright© 2017 Taiwan Biotech Co.,Ltd.